| Literature DB >> 28243950 |
Chunhua Ma1, Hongyan Long2, Chunhui Yang3, Wenjun Cai3, Tianzhu Zhang4, Wenhai Zhao3.
Abstract
The present study was designed to investigate the effects of pilose antler peptide (PAP) on lipopolysaccharide (LPS)-induced lung injury. BalB/c mice intraperitoneally received PAP (10 and 20 mg/kg) or dexamethasone (2 mg/kg) 1 h prior to intratracheal instillation of LPS. PAP significantly decreased lung wet-to-dry weight (W/D) ratio and lung myeloperoxidase (MPO) activity and restored LPS-induced lung histopathological changes. PAP also increased super oxide dismutase (SOD) level and inhibited malondialdehyde (MDA) content and levels of pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in bronchoalveolar lavage fluid (BALF) in LPS-stimulated mice. Furthermore, we demonstrated that PAP inhibited Rho/NF-κB pathway in LPS-induced mice. Our experimental results indicated that the protective mechanism of PAP might be attributed partly to the inhibition of Rho/NF-κB pathway.Entities:
Keywords: LPS; Rho/NF-κB; lung injury; pilose antler peptide
Mesh:
Substances:
Year: 2017 PMID: 28243950 DOI: 10.1007/s10753-017-0535-3
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092